Efficacy and Safety of Blood Derivative Therapy for Patients with COVID-19: A Systematic Review and Meta-Analysis

BACKGROUND: The outbreak of COVID-19 has resulted in more than 200 million infections and 4 million deaths. The blood derivative therapy represented by intravenous immunoglobulin (IVIG) and convalescent plasma (CP) therapy may be the promising therapeutics for COVID-19. METHODS: A systematic article...

Descripción completa

Detalles Bibliográficos
Autores principales: Fei, Zhangcheng, Chen, Zhongsheng, Du, Xi, Cao, Haijun, Li, Changqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148901/
https://www.ncbi.nlm.nih.gov/pubmed/35665313
http://dx.doi.org/10.1159/000524125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148901/
https://www.ncbi.nlm.nih.gov/pubmed/35665313
http://dx.doi.org/10.1159/000524125

Ejemplares similares